|
LCAR's FDA approved product could spark this breakout chart
|
 |
Good Morning, LCAR hit my radar a few weeks back when it lost its footing and began to form a new support level at its current levels around .01. But as I dug deeper into the company, I was impressed by the type of fundamentals it has as well:
- O/S is a measly 63Mil Shares.
- Float is a tiny 15Mil Shares.
- Insider Holding is a sizable 74pct.
- Incepted over 60 Years ago.
- Has an FDA approved product.
LCAR is in the wound healing business, but we are not talking about bandages, were talking skin care, Wound Dressing that is FDA approved and EU-Certified for the management of:
- Pressure ulcers (stages I-IV)
- Stasis ulcers
- 1st and 2nd degree burns
- Diabetic ulcers
- Post-surgical incisions
- Radiation dermatitis
- Cuts, abrasions and irritations
- Partial thickness wounds
- Skin conditions associated with peristomal care
Approved by the FDA in 1998, Catrix Wound Dressing is a natural, biode- gradable product, made from a specially processed bovine cartilage in the form of a fine white powder. Catrix has no chemical additives. Back in 1998... most products were not to concerned about chemical additives, yet LCAR was already putting out a product that was 10 years ahead of its time. Now combine this with a breakout chart that has one small resistance point 50pct from current levels and then next stop is around 150pct, and you have your self a formula for a parabolic mover. Even if LCAR chart only trends up to its first level of resistance, will you hate me for showing you a chart that could make you 50pct? What about 150pct? Start your research on LCAR right away and enjoy. Sincerely,
StockHideout
|
|
|
|
|